Advance Alzheimer’s biomarker detection with SPEAR UltraDetect pTau 217

SPEAR UltraDetect^™ pTau 217 is transforming Alzheimer’s disease research with its ultra-sensitive, blood-based assay. Using SPEAR Technology, this tool delivers high accuracy in distinguishing Alzheimer’s from other neurodegenerative diseases, enabling early detection, precise patient selection for clinical trials, and effective disease monitoring.